Comparing ketogenic and low-fat diets for diabetes management
Official title: Ketogenic Diet and Diabetes Demonstration Project
Run by University of New Mexico · NCT06115265 · Data updated 2026-11-12
This study tests whether a ketogenic diet or a low-fat diet works better for managing blood sugar and overall health in people with type 2 diabetes or prediabetes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | University of New Mexico Academic / other |
| Locations | 1 site (Albuquerque, New Mexico) |
| Status | Recruiting |
| Started | September 5, 2023 |
| Main results expected | October 30, 2026 |
| Study ends | October 30, 2026 |
| Registry record updated | September 3, 2026 |
| Trial ID | NCT06115265 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older with a BMI of 27 kg/m2 or higher and elevated hemoglobin A1c or fasting plasma glucose levels.
✕Probably not a fit
Patients with known cardiovascular disease, advanced renal or liver disease, or those requiring insulin will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Ketogenic Diet and Diabetes Demonstration Project (KDDP) is a 12-month pilot study designed to compare the metabolic effects of a medically-supervised ketogenic diet against a low-fat diet as part of the National Diabetes Prevention Program (NDPP). Participants in the KDDP arm will receive education on maintaining a ketogenic diet with less than 20g of carbohydrates per day, while those in the NDPP arm will follow a low-fat diet. Both groups will undergo regular monitoring of various health parameters, including glycemic control and lipid levels, to assess the effectiveness of each dietary approach. The study aims to provide insights into how these diets impact individuals with type 2 diabetes or prediabetes.
Why it matters
Potential benefit: If successful, this study could provide a more effective dietary intervention for managing type 2 diabetes and prediabetes.
How similar studies have gone: Previous studies have shown promising results for ketogenic diets in managing diabetes, suggesting that this approach may be effective, though the specific comparison to the NDPP is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Men and women ≥ 18 years old * BMI ≥27 kg/m2 * Hemoglobin A1c ≥ 5.7% and/or fasting plasma glucose of 100-125 mg/dL Exclusion Criteria: * Known clinical cardiovascular disease (i.e. prior stroke, myocardial infarction, peripheral artery disease) * LDL cholesterol ≥ 190 mg/dL * Triglycerides ≥ 500 mg/dL * History of type 1 diabetes * History of diabetic ketoacidosis * Individuals requiring insulin * Advanced renal disease * Advanced liver disease * Terminal cancer * Pregnancy
Where it's running
-
University of New Mexico
Albuquerque, New Mexico, United States Recruiting
Study contacts
- Principal investigator: Kristen Gonzales, MD — University of New Mexico
- Study coordinator: Kristen M Gonzales, MD
- Email: KrGonzales@salud.unm.edu
- Phone: 505-272-3840
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding how metabolism and inflammation affect diabetes in teens
This study is trying to see how body weight, lifestyle, and diet affect inflammation and metabolism in teens to better understand diabetes risk.
-
Lifestyle Metabotype Study B: Understanding Personalized Glucose Responses
This study tests how lifestyle, metabolism, and brain energy use relate to each person’s blood sugar response after meals, across people with and without prediabetes or type 2 diabetes.
-
Lifestyle Metabotype Study: How Daily Habits Shape Blood Sugar
This observational study tests whether personal lifestyle and biological factors can predict how a person’s blood sugar responds after meals.
-
Switching to Zenagamtide From Tirzepatide in Adults With Overweight or Obesity With or Without Type 2 Diabetes
This study tests whether adults who are overweight or have obesity (with or without type 2 diabetes) can switch from tirzepatide to a new treatment called zenagamtide to find a tolerable dose.
-
Switching to Zenagamtide from Semaglutide in adults with overweight or obesity, with or without type 2 diabetes
This study tests whether adults who are already taking semaglutide can successfully switch to zenagamtide at different doses to see which dose works best.
-
Using Multimodal Ultrasound to Check Muscle Mass in Metabolic Disease Patients
This study tests whether a multimodal ultrasound approach can accurately measure muscle mass in people with metabolic syndrome, obesity, sarcopenia, or type 2 diabetes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.